Anadarko Nursing & Rehab in Anadarko, OK

Anadarko Nursing & Rehab is a medicare and medicaid certified nursing home in Anadarko, Oklahoma. It is located in Caddo county at 300 West Washington, Anadarko, Oklahoma 73005. You can reach out to the office of Anadarko Nursing & Rehab via phone at (405) 247-3346. This skilled nursing facility has 92 federally certified beds with average occupancy rate of 67.61%. Its legal business name is Anadarko Nursing & Rehabilitation Llc and has the following ownership type - For Profit - Individual.

Anadarko Nursing & Rehab (Medicare CCN 375477) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2005 (19 years certified) and the last quality survey was conducted in February, 2019.

Name	Anadarko Nursing & Rehab
Location	300 West Washington, Anadarko, Oklahoma
Certified By	Medicare and Medicaid
No. of Certified Beds	92
Occupancy Rate	67.61%
Medicare ID (CCN)	375477
Legal Business Name	Anadarko Nursing & Rehabilitation Llc
Ownership Type	For Profit - Individual

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Anadarko Nursing & Rehab from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Anadarko Nursing & Rehab are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Anadarko Nursing & Rehab give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

New hydrogel prevents the formation of adhesions after cardiac surgery

A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers.

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

Anacor Pharmaceuticals enrolls first patient in AN2728 Phase 3 trial for treatment of atopic dermatitis

Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.

Tips to help minimize risks associated with acid reflux disease

While the overall death rates from several cancers such as breast and lung have gone down, there has been a meteoric rise in cases of esophageal cancer. Studies have shown that from 1975 to 2001, the incidence of esophageal adenocarcinoma rose approximately sixfold in the United States (from four to 23 cases per million), a relative increase greater than that for melanoma, breast, or prostate cancer.

Read more Medical News

› Verified 3 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$6655
Number of Payment Denials	0
Total Number of Penalties	1

The resident survey data of Anadarko Nursing & Rehab is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	5.98	14.46
Percentage of long-stay residents who lose too much weight	5.5	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	23.85	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	3.26	1.79
Percentage of long-stay residents with a urinary tract infection	0.48	2.65
Percentage of long-stay residents who have depressive symptoms	0.48	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	3.43	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	92.27	93.87
Percentage of long-stay residents who received an antipsychotic medication	44.64	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	69.44	83.88